Pharmaceutical and healthcare information provider IMS Health, US, has announced that its Board of Directors has elected Dr. Bradley T. Sheares as a director, effective April 21, 2009. Dr. Sheares' career spans more than 20 years in the pharmaceutical industry. Most recently, he served as chief executive officer of Reliant Pharmaceuticals, Inc., a company with integrated sales, marketing and development expertise that marketed a portfolio of branded cardiovascular medicines.
Dr. Sheares is the former chair of the Board of Directors of the National Pharmaceutical Council, which focuses on broadly communicating the economic, clinical and societal value of pharmaceuticals. He serves on the boards of directors of Honeywell International, a diversified technology and manufacturing company; The Progressive Corporation, one of the nation's largest insurance holding companies; and Covance, a global leader in drug development services.
Operating in more than 100 countries, IMS Health offers market intelligence products and services that are integral to clients' day-to-day operations. These include portfolio optimisation capabilities; launch and brand management solutions; sales force effectiveness innovations; managed care and over-the-counter offerings; and consulting and services solutions that improve ROI and the delivery of quality healthcare worldwide.
